Clinical Trial

Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.

Name: Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients. — clinical trial record (NCT07486583)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.

Trial Details

NCT Number	NCT07486583
Lead Sponsor	Cairo University
Conditions	Chronic Idiopathic Urticaria
Enrollment	40 participants
Start Date	2026-04-30
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-20